300562 乐心医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.3583.348-3.1311.03811.486
总资产报酬率 ROA (%)2.2162.215-1.9370.5585.934
投入资产回报率 ROIC (%)2.5142.494-2.2400.6877.431

边际利润分析
销售毛利率 (%)36.60530.93823.69618.54425.011
营业利润率 (%)6.8343.904-3.8600.0055.399
息税前利润/营业总收入 (%)5.1272.646-7.3490.1166.984
净利润/营业总收入 (%)6.6003.528-3.586-0.0155.079

收益指标分析
经营活动净收益/利润总额(%)117.84969.272-12.094-131.68191.969
价值变动净收益/利润总额(%)-0.62310.03314.150-115.068-0.541
营业外收支净额/利润总额(%)0.832-4.2737.743102.655-0.336

偿债能力分析
流动比率 (X)1.9682.0421.9651.6741.300
速动比率 (X)1.7881.8651.7431.3810.983
资产负债率 (%)35.97234.20135.44641.6330.526
带息债务/全部投入资本 (%)23.23820.95823.55227.43738.090
股东权益/带息债务 (%)317.741362.241310.154255.804159.061
股东权益/负债合计 (%)181.212195.475184.539141.19189.769
利息保障倍数 (X)-2.906-2.4082.3220.3984.357

营运能力分析
应收账款周转天数 (天)78.13181.28498.88567.84765.152
存货周转天数 (天)51.79458.31270.88052.76657.327